Skip to content
‹ Back to IndustriesSciences

Virgin Galactic Test Flight Reaches Space From New Mexico

(Bloomberg) — Virgin Galactic Holdings Inc. flew a test flight to space for the first time in more than two years, a critical step in its path toward commercial service following a series of issues that have beset the company. The VSS Unity test flight from New Mexico on Saturday helps put the company back…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · Sir Richard BransonSpaceTest FlightVirgin Galactic
Share
Virgin Galactic Test Flight Reaches Space From New Mexico

Key takeaways

01

(Bloomberg) — Virgin Galactic Holdings Inc.

02

flew a test flight to space for the first time in more than two years, a critical step in its path toward commercial service following a series of issues that have beset the company.

03

The VSS Unity test flight from New Mexico on Saturday helps put the company back…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

(Bloomberg) —

Virgin Galactic Holdings Inc. flew a test flight to space for the first time in more than two years, a critical step in its path toward commercial service following a series of issues that have beset the company.

The VSS Unity test flight from New Mexico on Saturday helps put the company back on its stated schedule of flying company founder Richard Branson to suborbital space as early as this summer, and resuming ticket sales.

Branson and Chief Executive Officer Michael Colglazier observed the flight from Virgin Galactic’s operations center at Spaceport America, near Truth or Consequences, New Mexico.

@virgingalactic #UNITY21 pic.twitter.com/c6k4A3H89I
— Richard Branson (@richardbranson) May 22, 2021

“It was a very, very clean and elegant flight,” Colglazier said Saturday in a telephone interview, calling the test a success that met each objective, including the first trip with a new, more precise flight control system to improve the spacecraft’s handling.

The unexpected part of the event, he said, was when an ecstatic Branson sprayed him with champagne following the flight. “That was unusual and not expected,” Colglazier said.

Piloted by CJ Sturckow and Dave Mackay, the VSS Unity flight was the company’s first to space from New Mexico, which became the third U.S. state from which people have flown to space after Florida and California. A 1982 Space Shuttle mission landed at White Sands Missile Range in New Mexico.

VSS Unity was traveling at a speed of Mach 3 after being released from the mothership, VMS Eve, and reached space at an altitude of 55.45 miles (89.2 kilometers), before landing at Spaceport America, according to a statement.

The flight was the company’s first rocket burn since February 2019, when Beth Moses, a Virgin engineer and astronaut instructor, joined a test flight from Mojave, California. The trip paves the way for Virgin’s next test flight, which is expected to carry additional employees as the company prepares for its commercial service.

The company isn’t ready to say when it will be ready for the next test flight with four employees. “You can imagine I’m getting a lot of people pinging me with ‘I’d like to be on,’” Colglazier said.

After the 2019 flight engineers discovered hull damage on the spacecraft from air pressure that had built up after ventilating holes were accidentally covered, according to “Test Gods,” a book published this month by New Yorker writer Nicholas Schmidle, who was given access to observe the company for several years.

Amid delays caused by the pandemic, with many employees working from home, Virgin Galactic’s testing program suffered another setback in December when VSS Unity dropped from its carrier aircraft but the rocket motor failed to ignite. The craft glided back to Spaceport America and landed without incident.

A second flight attempt in February was scuttled by electrical interference detected in the spacecraft’s avionics system. The company spent about two months repairing the interference issues, which engineers traced to the installation of a more powerful flight computer last year.

Earlier this month, Virgin Galactic warned investors that it was reviewing “fatigue and stress” issues in its four-engine carrier aircraft, VMS Eve. The airplane was cleared to fly after “a detailed inspection and thorough analysis,” the company said Thursday.

—

By Justin Bachman

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512